Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0000950170-24-104784
Filing Date
2024-09-09
Accepted
2024-09-09 16:32:00
Documents
1
Effectiveness Date
2024-09-09

Document Format Files

Seq Description Document Type Size
1 S-8 POS pos_am_form_s-8_no._333-.htm S-8 POS 48000
  Complete submission text file 0000950170-24-104784.txt   49191
Mailing Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607
Business Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-253218 | Film No.: 241287637
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)